PACB Past Earnings image   This PACB past earnings page last updated 8/5/2022
PACB Past Earnings
PeriodPast Earnings DateAdj. EPS
Q2 20228/3/2022-0.340
Q1 20225/4/2022-0.370
Q4 20212/15/2022-0.300
Q3 202111/2/2021-0.230
Q2 20218/3/2021-0.210
Q1 20214/29/2021-0.450
Q4 20202/10/20210.370
Q3 202011/2/2020-0.140
Q2 20208/3/2020-0.150
Q1 20205/6/20200.010
Q4 20192/6/20200.000
Q3 201911/7/2019-0.190
Q2 20198/6/2019-0.160
Q1 20195/3/2019-0.200
Q4 20182/11/2019-0.21
Q3 201811/1/2018-0.19
Q2 20188/2/2018-0.17
Q1 20185/2/2018-0.2
Q4 20172/1/2018-0.18
Q3 201711/2/2017-0.19
Q2 20178/2/2017-0.26
Q1 20174/26/2017-0.24
Q4 20162/2/2017-0.21
Q3 201611/2/2016-0.19
Q2 20168/4/2016-0.21
Q1 20164/21/2016-0.23
Q4 20152/3/2016-0.02
Q3 201510/22/2015-0.26
Q2 20158/5/2015-0.14
Q1 20155/5/2015-0.27
Q4 20142/3/2015-0.26
Q3 201410/23/2014-0.13
Q2 20147/24/2014-0.27
Q1 20144/30/2014-0.28
Q4 20132/4/2014-0.26
Q3 201310/22/2013-0.31
Q2 20138/1/2013-0.33
Q1 20134/23/2013-0.37
Q4 20122/5/2013-0.39
Q3 201210/25/2012-0.410
Q2 20127/26/2012-0.4
PACB Past Revenue
PeriodPast Earnings DateGAAP
Q2 20228/3/20220.04B
Q1 20225/4/20220.03B
Q4 20212/15/20220.04B
Q3 202111/2/20210.03B
Q2 20218/3/20210.03B
Q1 20214/29/20210.03B
Q4 20202/10/20210.03B
Q3 202011/2/20200.02B
Q2 20208/3/20200.02B
Q1 20205/6/20200.02B
Q4 20192/6/20200.03B
Q3 201911/7/20190.02B
Q2 20198/6/20190.02B
Q1 20195/3/20190.02B
Q4 20182/11/201919.53M
Q3 201811/1/201818.16M
Q2 20188/2/201821.58M
Q1 20185/2/201819.36M
Q4 20172/1/201824.93M
Q3 201711/2/201723.55M
Q2 20178/2/201720.07M
Q1 20174/26/201724.91M
Q4 20162/2/201725.72M
Q3 201611/2/201625.12M
Q2 20168/4/201620.75M
Q1 20164/21/201619.13M
Q4 20152/3/201636.28M
Q3 201510/22/201513.92M
Q2 20158/5/201524.94M
Q1 20155/5/201517.60M
Q4 20142/3/201516.90M
Q3 201410/23/201420.60M
Q2 20147/24/201411.40M
Q1 20144/30/201411.60M
Q4 20132/4/20149.13M
Q3 201310/22/20137.40M
Q2 20138/1/20136.05M
Q1 20134/23/20135.58M
Q4 20122/5/20135.88M
Q3 201210/25/20120.00B
Q2 20127/26/20127.29M
Quotes delayed 20 minutes

Email EnvelopeFree PACB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Pacific Biosciences (PACB) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

PAHC Past Earnings
PALI Past Earnings
PASG Past Earnings
PAVM Past Earnings
PBH Past Earnings
PBLA Past Earnings
PBYI Past Earnings
PCRX Past Earnings
PCSA Past Earnings
PCVX Past Earnings

PACB Past Earnings Q&A

What was the best and worst PACB past earnings results?
For Pacific Biosciences, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest PACB past earnings result in our data set was 0.370/share posted in Q4 2020, while the lowest was in Q1 2021 when PACB posted -0.450/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2015 when PACB reported 36.28M in revenue, while the quarter with the lowest revenue in our data set was Q3 2012 at 0.00B of revenue.

  Suggested answer: There are 41 PACB past earnings results in our data set.

On this page we presented the PACB past earnings date information for Pacific Biosciences. Reviewing that PACB Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2020, when PACB posted adjusted EPS of 0.370/share. Meanwhile the lowest PACB past earnings result was in Q1 2021, when PACB posted adjusted EPS of -0.450/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2015 when PACB reported 36.28M in revenue, while the smallest revenue quarter was Q3 2012 when PACB reported 0.00B in revenue.

Any self directed investor doing their due diligence on PACB or any other given stock can benefit from researching all of the Pacific Biosciences past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Pacific Biosciences past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for PACB. Thanks for visiting, and the next time you need to research PACB past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: TSLF shares outstanding history, ETFs Holding DAVE, ACRS Price Target.

 

PACB Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.